Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

전이성신세포암 표적치료제의 부작용 심각도 및 위해에 대한 전문가그룹별 비교분석

Full metadata record
DC Field Value Language
dc.contributor.author박미혜-
dc.contributor.author이진이-
dc.contributor.author이의경-
dc.date.available2021-02-22T11:01:45Z-
dc.date.issued2011-07-
dc.identifier.issn1226-6051-
dc.identifier.urihttps://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/6980-
dc.description.abstractThe perception of the 20 adverse events of targeted therapy for metastatic renal cell carcinoma was compared among medical professionals. Thirty-seven oncologists, 167 nurses and 79 pharmacists participated in the survey, and the response rate was 61.9%, 98.2%, 84.9%, respectively. Results showed that the most serious adverse event was GI perforation (8.83 points, 10 being the most serious), whereas the least serious was anemia (5.32 points). There were significant differences among oncologists, nurses and pharmacists especially for the moderately-serious adverse event such as wound-healing complication and lymphopenia. Adverse Events Composite Score (AECS) for each targeted therapy was calculated by multiplying adverse event incidence rate and seriousness score. Sunitinib had the highest score at 6.86point and bevacizumab had the lowest at 2.1. Among professional groups oncologists showed the lowest AECS,whereas nurses had the highest. The gap on the perception of the adverse events among medical professionals needs to be reduced to get better outcomes of medical therapies for cancer patients.-
dc.format.extent6-
dc.language한국어-
dc.language.isoKOR-
dc.publisher한국임상약학회-
dc.title전이성신세포암 표적치료제의 부작용 심각도 및 위해에 대한 전문가그룹별 비교분석-
dc.title.alternativeComparative Analysis of the Seriousness of the Adverse Events and Risk of Targeted Therapy for Metastatic Renal Cell Carcinoma Among Medical Professionals-
dc.typeArticle-
dc.publisher.location대한민국-
dc.identifier.bibliographicCitation한국임상약학회지, v.21, no.2, pp 100 - 105-
dc.citation.title한국임상약학회지-
dc.citation.volume21-
dc.citation.number2-
dc.citation.startPage100-
dc.citation.endPage105-
dc.identifier.kciidART001570738-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClasskci-
dc.subject.keywordAuthormetastatic renal cell carcinoma-
dc.subject.keywordAuthortargeted therapy-
dc.subject.keywordAuthoradverse drug event-
dc.subject.keywordAuthorseriousness-
dc.subject.keywordAuthorrisk-
dc.identifier.urlhttps://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001570738-
Files in This Item
Go to Link
Appears in
Collections
특수대학원 > 임상약학대학원 > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE